## Hormonal IUCD (LNG-IUS) vs Copper IUCD: Clinical Indications **Key Point:** The LNG-IUS is the most commonly preferred IUCD in women with menorrhagia because it reduces menstrual bleeding by 50–90% through direct endometrial suppression. ### Comparative Efficacy in Menorrhagia | Feature | Copper IUCD | LNG-IUS (Mirena) | |---------|-------------|------------------| | Effect on bleeding | **Increases** by 20–30% | **Reduces** by 50–90% | | Dysmenorrhoea | Worsens | Improves | | Amenorrhoea rate | <5% | 20–30% at 1 year | | Endometrial thickness | Normal/increased | Atrophic | | Ideal for menorrhagia | No (contraindicated) | Yes (therapeutic) | ### Mechanism of LNG-IUS Action on Endometrium 1. **Local hormone release:** 20 μg levonorgestrel/day released directly into uterine cavity 2. **Endometrial atrophy:** Suppresses endometrial proliferation and glandular development 3. **Reduced vascularity:** Decreases endometrial blood vessel formation 4. **Altered prostaglandin profile:** Reduces PGF₂α, limiting uterine contractility 5. **Result:** Dramatically reduced menstrual flow (therapeutic benefit) **High-Yield:** The LNG-IUS is indicated for: - Menorrhagia (primary indication) - Dysmenorrhoea - Endometrial hyperplasia (preventive/therapeutic) - Adenomyosis (off-label but effective) **Clinical Pearl:** In a woman with heavy periods, the LNG-IUS is superior because it **treats the underlying problem** (excessive bleeding) while providing contraception — a "two-for-one" benefit. Copper IUCDs would worsen her symptoms. ### Why Other Options Are Incorrect - **Cost:** Copper IUCDs are cheaper, but LNG-IUS cost is justified by therapeutic benefit in menorrhagia - **Ectopic prevention:** Both IUCDs prevent ectopic pregnancy equally well (failure rate ~0.2%) - **PID risk:** No significant difference between types; risk is highest in first 3 weeks post-insertion
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.